Synergistic antitumor effect of BRMS1 and sorafenib via inhibition of the PI3K/AKT/mTOR/ERK signaling pathway

Jingyun Jin(Pingjin Hospital), Shengkai Sun(Pingjin Hospital)
Oncology Reports
June 24, 2019
Cited by 6


Related Papers

No related papers found

Powered by citation graph analysis